{"nct_id":"NCT02383966","title":"Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2015-07-31","start_date_type":"ACTUAL","primary_completion_date":"2018-01-19","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}